Fundz

Vitasense raised funding from Crown Wealth to refine its third-generation prototype, enhance regulatory compliance, and prepare for large-scale clinical testing.

PRIVATEMar 03, 2025

Round Type

Funding Round

PhiladelphiaBiotechnologyHealth CareMedical Device

Investors

KB Global Holding LimitedCrown Wealth

Description

Vitasense, a Philadelphia-based startup focused on non-invasive glucose monitoring technology, secured funding from Crown Wealth, in collaboration with KB Global Holding Limited and other universities. The specifics of the funding amount were not disclosed.

Quick answer

Vitasense raised an undisclosed amount in a Funding Round round, dated March 3, 2025. Investors: KB Global Holding Limited and Crown Wealth. Vitasense is based in Philadelphia, Pennsylvania, United States.

How much did Vitasense raise?
Vitasense raised an undisclosed amount in a Funding Round round on March 3, 2025.
Who invested in Vitasense?
KB Global Holding Limited and Crown Wealth are named as investors in this round.
What does Vitasense do?
Vitasense is a Philadelphia, PA-based startup dedicated to developing non-invasive wearable glucose monitoring technology.
Where is Vitasense based and how big is it?
Vitasense is based in Philadelphia, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as Vitasense that raised within 45 days of this round, from Fundz verified event records.

  • AMT Medical raised $25M (Series B) on April 17, 2025.
  • Medcura raised $29M on April 16, 2025.
  • Shape Memory Medical raised $4.4M (Series C) on April 15, 2025.
  • Flyte raised $137K (Seed) on April 15, 2025.
  • Perkant Tech raised $772K (Seed) on April 3, 2025.
  • CMR Surgical raised $200M on April 2, 2025.

Who to call at Vitasense, and when

A new round usually means Vitasense is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vitasense raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vitasense, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vitasense. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vitasense

Location

Philadelphia, Pennsylvania, United States

About

Vitasense is a Philadelphia, PA-based startup dedicated to developing non-invasive wearable glucose monitoring technology. The company provides a glucose monitoring armband designed to address the issue of undiagnosed diabetes with a non-invasive and pain-free alternative to traditional finger pricking methods. Their technology utilizes advanced materials and sensors for accurate real-time glucose level monitoring. Founded and led by Max Kopp, Vitasense aims to enhance regulatory compliance and prepare for large-scale clinical testing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vitasense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vitasense's next move

See what Strategic adds

Vitasense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.